Clinical Trials Insight: 700046954

Trial Profile

Clinical Trials Insight: 700046954

Phase of Trial: Phase I

Latest Information Update: 17 Jul 2009

At a glance

  • Drugs NI 0801 (Primary)
  • Indications Allotransplant rejection; Atherosclerosis; Coeliac disease; Hepatic fibrosis; Inflammation; Lupus vulgaris; Multiple sclerosis; Myasthenia gravis; Nephritis; Psoriasis; Pulmonary fibrosis; Rheumatoid arthritis; Systemic lupus erythematosus; Type 1 diabetes mellitus; Ulcerative colitis
  • Focus Adverse reactions
  • Sponsors NovImmune SA
  • Most Recent Events

    • 17 Jul 2009 New trial record.
    • 13 Jul 2009 Results have been announced in a NovImmune media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top